CBAY logo

CymaBay Therapeutics (CBAY) Depreciation And Amortization

Annual D&A

$681.00 K
+$56.00 K+8.96%

31 December 2023

3-Year Change

+1.79%
CBAY annual depreciation & amortization is up +1.79% over the past 3 years

All-time High

$681.00 K
CBAY annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$132.75 M
CBAY annual total expenses is $132.75 million
Annual Operating Expenses$132.75 M
CBAY annual total operating expenses is $132.75 million
Annual Revenue$31.07 M
CBAY annual revenue is $31.07 million
Annual Net Income-$105.37 M
CBAY annual net profit is -$105.37 million

CBAY Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$56.00 K
-$159.00 K-73.95%

31 December 2023

3-Year Change

-63.64%
CBAY quarterly depreciation & amortization is down -63.64% over the past 3 years

All-time High

$215.00 K
CBAY quarterly depreciation & amortization is currently -73.95% below its historical high of $215.00 thousand
Quarterly Total Expenses$42.55 M
CBAY quarterly total expenses is $42.55 million
Quarterly Operating Expenses$42.55 M
CBAY quarterly total operating expenses is $42.55 million
Quarterly Revenue$57.00 K
CBAY quarterly revenue is $57.00 thousand
Quarterly Net Income-$41.90 M
CBAY quarterly net profit is -$41.90 million

CBAY Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$681.00 K
-$44.00 K-6.07%

31 December 2023

3-Year Change

+1.79%
CBAY TTM depreciation & amortization is up +1.79% over the past 3 years

All-time High

$725.00 K
CBAY TTM depreciation & amortization is currently -6.07% below its historical high of $725.00 thousand
Annual Total Expenses$132.75 M
CBAY annual total expenses is $132.75 million
Annual Operating Expenses$132.75 M
CBAY annual total operating expenses is $132.75 million
TTM Revenue$31.07 M
CBAY TTM revenue is $31.07 million
TTM Net Income-$105.37 M
CBAY TTM net profit is -$105.37 million

CBAY TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+1.8%-63.6%+1.8%
5 y5 years+19.1%-62.7%+19.1%

CBAY Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-74.0%-6.1%

CymaBay Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2023
$681.00 K(+9.0%)
$56.00 K(-74.0%)
$681.00 K(-6.1%)
Sept 2023
-
$215.00 K(+1.9%)
$725.00 K(+4.8%)
June 2023
-
$211.00 K(+6.0%)
$692.00 K(+5.6%)
Mar 2023
-
$199.00 K(+99.0%)
$655.00 K(+4.8%)
Dec 2022
$625.00 K(-6.6%)
$100.00 K(-45.1%)
$625.00 K(-8.0%)
Sept 2022
-
$182.00 K(+4.6%)
$679.00 K(+0.9%)
June 2022
-
$174.00 K(+3.0%)
$673.00 K(-0.1%)
Mar 2022
-
$169.00 K(+9.7%)
$674.00 K(+0.7%)
Dec 2021
$669.00 K(+5.9%)
$154.00 K(-12.5%)
$669.00 K(-1.5%)
Sept 2021
-
$176.00 K(+0.6%)
$679.00 K(+2.6%)
June 2021
-
$175.00 K(+6.7%)
$662.00 K(+3.0%)
Mar 2021
-
$164.00 K(0.0%)
$643.00 K(+1.7%)
Dec 2020
$632.00 K(+10.5%)
$164.00 K(+3.1%)
$632.00 K(+2.3%)
Sept 2020
-
$159.00 K(+1.9%)
$618.00 K(+2.5%)
June 2020
-
$156.00 K(+2.0%)
$603.00 K(+2.7%)
Mar 2020
-
$153.00 K(+2.0%)
$587.00 K(+2.6%)
Dec 2019
$572.00 K(+444.8%)
$150.00 K(+4.2%)
$572.00 K(+17.2%)
Sept 2019
-
$144.00 K(+2.9%)
$488.00 K(+36.3%)
June 2019
-
$140.00 K(+1.4%)
$358.00 K(+55.0%)
Mar 2019
-
$138.00 K(+109.1%)
$231.00 K(+120.0%)
Dec 2018
$105.00 K
$66.00 K(+371.4%)
$105.00 K(+118.8%)
Sept 2018
-
$14.00 K(+7.7%)
$48.00 K(+14.3%)
DateAnnualQuarterlyTTM
June 2018
-
$13.00 K(+8.3%)
$42.00 K(+10.5%)
Mar 2018
-
$12.00 K(+33.3%)
$38.00 K(+8.6%)
Dec 2017
$35.00 K(+20.7%)
$9000.00(+12.5%)
$35.00 K(+2.9%)
Sept 2017
-
$8000.00(-11.1%)
$34.00 K(-5.6%)
June 2017
-
$9000.00(0.0%)
$36.00 K(+9.1%)
Mar 2017
-
$9000.00(+12.5%)
$33.00 K(+13.8%)
Dec 2016
$29.00 K(+31.8%)
$8000.00(-20.0%)
$29.00 K(+11.5%)
Sept 2016
-
$10.00 K(+66.7%)
$26.00 K(+18.2%)
June 2016
-
$6000.00(+20.0%)
$22.00 K(+4.8%)
Mar 2016
-
$5000.00(0.0%)
$21.00 K(-4.5%)
Dec 2015
$22.00 K(+22.2%)
$5000.00(-16.7%)
$22.00 K(0.0%)
Sept 2015
-
$6000.00(+20.0%)
$22.00 K(+4.8%)
June 2015
-
$5000.00(-16.7%)
$21.00 K(0.0%)
Mar 2015
-
$6000.00(+20.0%)
$21.00 K(+16.7%)
Dec 2014
$18.00 K(-67.3%)
$5000.00(0.0%)
$18.00 K(0.0%)
Sept 2014
-
$5000.00(0.0%)
$18.00 K(-18.2%)
June 2014
-
$5000.00(+66.7%)
$22.00 K(-31.3%)
Mar 2014
-
$3000.00(-40.0%)
$32.00 K(-41.8%)
Dec 2013
$55.00 K(-53.8%)
$5000.00(-44.4%)
$55.00 K(+10.0%)
Sept 2013
-
$9000.00(-40.0%)
$50.00 K(+22.0%)
June 2013
-
$15.00 K(-42.3%)
$41.00 K(+57.7%)
Mar 2013
-
$26.00 K
$26.00 K
Dec 2012
$119.00 K
-
-

FAQ

  • What is CymaBay Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for CymaBay Therapeutics?
  • What is CymaBay Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for CymaBay Therapeutics?
  • What is CymaBay Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for CymaBay Therapeutics?

What is CymaBay Therapeutics annual depreciation & amortization?

The current annual D&A of CBAY is $681.00 K

What is the all time high annual D&A for CymaBay Therapeutics?

CymaBay Therapeutics all-time high annual depreciation & amortization is $681.00 K

What is CymaBay Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of CBAY is $56.00 K

What is the all time high quarterly D&A for CymaBay Therapeutics?

CymaBay Therapeutics all-time high quarterly depreciation & amortization is $215.00 K

What is CymaBay Therapeutics TTM depreciation & amortization?

The current TTM D&A of CBAY is $681.00 K

What is the all time high TTM D&A for CymaBay Therapeutics?

CymaBay Therapeutics all-time high TTM depreciation & amortization is $725.00 K